Home > Quotes > XBI

SPDR Series Trust SPDR S&P Biotech ETF Stock Quote & Summary Data

(ETF)
XBI 
$225.5
*  
1.13
0.5%
Get XBI Alerts
*Delayed - data as of Mar. 31, 2015  -  Find a broker to begin trading XBI now


Community Rating:
View:    XBI Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks
1 Year Target
Today's High /Low "Today's High" The highest sales price the stock has achieved during the regular trading hours, the intra-day high.
"Today's Low" The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.
 / 
Share Volume "Share Volume" is the number of shares of the stock traded on the listing exchange during current trading hours. It does not include after hours volume.
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 497,431
Previous Close "Previous Close" is the previous trading day's last reported trade price during official trading hours. $ 224.37
52 Week High/Low "52 Week High" is the highest sales price the stock has achieved during the regular trading hours during the most recent 52 week period.
"52 Week Low" is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.
$ 244.98 / $ 115.3117
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 1,984,400,000
Annualized dividend $ 0.9815
Ex Dividend Date Mar. 20, 2015
Dividend Payment Date Mar. 30, 2015
Current Yield Indicated yield represents annual dividends divided by current stock price. 0.44 %
Beta "Beta" is a volatility measurement of a stock mutual fund or ETF versus a comparable benchmark like the S&P 500 stock index. A stock fund or ETF with a higher beta than the S&P 500 will rise or fall to a greater degree. In contrast, a stock fund or ETF with a low beta will rise or fall less. 0

Intraday Chart

Description

The SPDR S&P Biotech ETF seeks to replicate as closely as possible, before expenses, the performance of the S&P Biotechnology Select Industry Index (the "Index"). The Index represents the biotechnology sub-industry portion of the S&P Total Stock Market Index. The Index is one of nineteen (19) of the S&P Select Industry Indexes, each designed to measure the performance of a narrow sub-industry determined based on the Global Industry Classification Standards (GICS). The Index consists of the S&P Select Industry Indexes constituents belonging to the particular GICS sub-industry (e.g., biotechnology) that satisfy the following criteria: (i) rank within the 90th percentile of the float-adjusted market capitalization of the GICS sub-industry; (ii) are a U.S.-based company; and (iii) have a liquidity ratio greater than 60%. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.


Underlying Index S&P Biotechnology Select Industry Index
Management Fee 0.35
Asset Class equity
Leverage 1

News for XBI

Top Holdings
PCYC Pharmacyclics Inc 1.86%
BMRN BioMarin Pharmaceutical Inc 1.3%
INCY Incyte Corp 1.17%
BIIB Biogen Idec Inc 1.17%
REGN Regeneron Pharmaceuticals Inc 1.04%
VRTX Vertex Pharmaceuticals Inc 1.03%
CELG Celgene Corp 1.01%
AMGN Amgen Inc 0.95%
GILD Gilead Sciences Inc 0.93%
ALXN Alexion Pharmaceuticals Inc 0.91%

Research Brokers before you trade

Want to trade FX?